William A Werbel, Diane M Brown, Oyinkansola T Kusemiju, Brianna L Doby, Shanti M Seaman, Andrew D Redd, Yolanda Eby, Reinaldo E Fernandez, Niraj M Desai, Jernelle Miller, Gilad A Bismut, Charles S Kirby, Haley A Schmidt, William A Clarke, Michael Seisa, Christos J Petropoulos, Thomas C Quinn, Sander S Florman, Shirish Huprikar, Meenakshi M Rana, Rachel J Friedman-Moraco, Aneesh K Mehta, Peter G Stock, Jennifer C Price, Valentina Stosor, Shikha G Mehta, Alexander J Gilbert, Nahel Elias, Michele I Morris, Sapna A Mehta, Catherine B Small, Ghady Haidar, Maricar Malinis, Jennifer S Husson, Marcus R Pereira, Gaurav Gupta, Jonathan Hand, Varvara A Kirchner, Avinash Agarwal, Saima Aslam, Emily A Blumberg, Cameron R Wolfe, Kevin Myer, R Patrick Wood, Nikole Neidlinger, Sara Strell, Marion Shuck, Harry Wilkins, Matthew Wadsworth, Jennifer D Motter, Jonah Odim, Dorry L Segev, Christine M Durand, Aaron A R Tobian
BACKGROUND: Organ transplantation from donors with HIV to recipients with HIV (HIV D+/R+) presents risks of donor-derived infections. Understanding clinical, immunologic, and virologic characteristics of HIV+ donors is critical for safety. METHODS: We performed a prospective study of donors with HIV-positive and HIV false-positive (FP) testing within the HOPE in Action studies of HIV D+/R+ transplantation (ClinicalTrials.gov NCT02602262; NCT03500315; NCT03734393)...
August 28, 2021: Clinical Infectious Diseases